PERSONALIZED MEDICINE COALITION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

GINA MURDOCH

Phone

2025891770

Tax Period

2025-01-01 to 2025-12-31

PERSONALIZED MEDICINE COALITION, founded in 2003, is a community nonprofit in the Diseases & Disorders sector that reported $2.1M in total revenue in fiscal year 2025. Revenue fell 25% from the prior year — a significant decline worth monitoring. Expenses of $2.5M exceeded revenue, resulting in a 21% operating deficit.

Mission

THE PERSONALIZED MEDICINE COALITION (PMC), REPRESENTING INNOVATORS, SCIENTISTS, PATIENTS, PROVIDERS AND PAYERS, PROMOTES THE UNDERSTANDING AND ADOPTION OF PERSONALIZED MEDICINE CONCEPTS, SERVICES AND PRODUCTS TO BENEFIT PATIENTS AND THE HEALTH SYSTEM.

Program Service Accomplishments

Program 1

Expenses: $589,812 Revenue: $475,134

PUBLIC AND SCIENCE POLICY (ADVOCACY): TO HELP FACILITATE THE DEVELOPMENT OF PERSONALIZED MEDICINE TESTS AND THERAPIES, PMC ENGAGES REGULATORS AND OTHER POLICYMAKERS TO ADVOCATE FOR CONTINUED...

PUBLIC AND SCIENCE POLICY (ADVOCACY): TO HELP FACILITATE THE DEVELOPMENT OF PERSONALIZED MEDICINE TESTS AND THERAPIES, PMC ENGAGES REGULATORS AND OTHER POLICYMAKERS TO ADVOCATE FOR CONTINUED INVESTMENTS IN BIOMEDICAL RESEARCH AS WELL AS MODERNIZED REGULATORY, COVERAGE AND PAYMENT POLICIES THAT SUPPORT ACCESS TO PERSONALIZED MEDICINE.

Program 2

Expenses: $268,704 Revenue: $475,134

EVIDENCE DEVELOPMENT: TO ENCOURAGE THE SWIFTER ADOPTION OF PERSONALIZED MEDICINE BY HEALTH CARE PROVIDERS, PMC HELPS BUILD THE EVIDENCE BASE NECESSARY TO DEMONSTRATE THE CLINICAL AND ECONOMIC VALUE...

Program 3

Expenses: $723,678 Revenue: $566,861

EDUCATION: TO RAISE THE PROFILE AND SCOPE OF PERSONALIZED MEDICINE, PMC PROACTIVELY EDUCATES DECISION-MAKERS ABOUT HOW THE FIELD CAN MAKE THE HEALTH SYSTEM MORE EFFECTIVE AND EFFICIENT BY TARGETING...

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $551,000

Program Service Revenue $1,516,057

Investment Income $31,451

Other Revenue $1,072

TOTAL REVENUE $2,099,580

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,274,985

Fundraising Expenses $183,123

Program Expenses $1,582,194

Other Expenses $1,272,065

TOTAL EXPENSES $2,547,050

Year-over-Year Comparison

	2025	2024	Change
Revenue	$2,099,580	$2,790,561	-0.2%
Expenses	$2,547,050	$3,342,547	-0.2%
Net Income	$-447,470	$-551,986	-0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$454,896

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LINCOLN NADAULD MD PHD	BOARD CHAIR	1.00	Officer Director	$0	$0	$0
LAUREN SILVIS JD	BOARD VICE CHAIR	1.00	Officer Director	$0	$0	$0
GABRIELE ALLEGRI	DIRECTOR	1.00	Director	$0	$0	$0
BRIAN CAVENEY MD	DIRECTOR	1.00	Director	$0	$0	$0
HELMY ELTOUKHY PHD	DIRECTOR	1.00	Director	$0	$0	$0
SARAH HERSEY	DIRECTOR	1.00	Director	$0	$0	$0
RICHARD KNIGHT	DIRECTOR	1.00	Director	$0	$0	$0
JAY G WOHLGEMUTH MD	DIRECTOR	1.00	Director	$0	$0	$0
JAMES W LILLARD PHD	DIRECTOR	1.00	Director	$0	$0	$0
HOWARD MCCLEOD PHARMD	DIRECTOR	1.00	Director	$0	$0	$0
ANDREA FERRIS	DIRECTOR	1.00	Director	$0	$0	$0
ELIZABETH O'DAY PHD	DIRECTOR	1.00	Director	$0	$0	$0
OMAR PEREZ PHD	DIRECTOR	1.00	Director	$0	$0	$0
CECILIA SCHOTT	DIRECTOR	1.00	Director	$0	$0	$0
PRASANTH REDDY MD	DIRECTOR	1.00	Director	$0	$0	$0
APOSTOLIA M TSIMBERIDOU MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL J VASCONCELLES MD	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL YBARRA MD PHRMA	DIRECTOR	1.00	Director	$0	$0	$0
JOSH OFFMAN MD	DIRECTOR	1.00	Director	$0	$0	$0
AMY NAYAR	FORMER PRESIDENT (THRU 1/23/2025)	40.00	Officer	$200,027	$0	$200,027
DARYL PRITCHARD	INTERIM PRESIDENT (SINCE 2/1/2025)	40.00	Officer	$242,704	$12,165	$254,869
CYNTHIA BENS	SVP, PUBLIC POLICY	40.00	Highest	$243,304	$24,587	$267,891
KAYLA S BROWN	FORMER VP, MEMBERSHIP & DEVELOPME	40.00	Highest	$128,450	$14,854	$143,304

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$2,099,580	$2,547,050	$1,665,677	$-447,470
2024	No data	No data	No data	No data
2023	$2,924,778	$3,355,017	$2,844,075	$-430,239
2022	$3,614,837	$3,763,895	$2,207,870	$-149,058
2021	$2,833,639	$2,518,911	$3,140,765	$314,728
2020	$2,330,013	$2,515,953	$2,772,916	$-185,940
2019	$3,067,007	$2,983,037	$2,687,682	$83,970
2018	$2,605,566	$2,354,812	$2,175,807	$250,754